Ambagon Therapeutics
Eindhoven, Netherlands ambagontx.com
From their website, Nov 2026
Work here? Claim this listing
About
Ambagon Therapeutics develops small-molecule molecular glues that stabilize 14-3-3:client protein complexes to modulate previously undruggable targets. It focuses on oncology, neurodegeneration, metabolic disorders, and infectious diseases. The company is based in Eindhoven, Netherlands.
Services
14-3-3 encyclopedia
Provides a systematic understanding of the 14-3-3:client interface to support predictive structure-chemotype pairing and streamline drug discovery.
Compound library screening
Uses a library of 14-3-3 privileged scaffolds, including natural products, drug-like compounds, and molecular fragments, to probe 14-3-3:client complexes.
High-throughput X-ray crystallography
Screens compounds using high-throughput X-ray crystallography as part of the drug discovery toolbox.
Biochemical assays
Runs biochemical assays to support structure-enabled medicinal chemistry optimization.
Biophysical assays
Runs biophysical assays to support structure-enabled medicinal chemistry optimization.
Cellular mechanistic assays
Runs cellular mechanistic assays to evaluate 14-3-3 molecular glue activity.
Pharmacodynamic assays
Runs pharmacodynamic assays within its drug discovery toolbox.
Functional assays
Runs functional assays to support medicinal chemistry optimization.
Capabilities
- Services
- Small molecule · Peptide · Small molecules
Locations
- Based in
- Eindhoven, Netherlands
- Sites
- Eindhoven, Netherlands
Contacts
- General enquiry
- info@ambagontx.com on their site
Similar suppliers
Work here? Claim this listing